346 related articles for article (PubMed ID: 12527934)
1. The usefulness of digital subtraction imaging with Levovist in the diagnosis of focal hepatic tumors.
Yamamoto K; Shiraki K; Nakanishi S; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Fuke H; Hashimoto A; Shimizu A; Okuda Y; Nakano T
Int J Oncol; 2003 Feb; 22(2):353-8. PubMed ID: 12527934
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of digital subtraction imaging with Levovist in the diagnosis of hepatocellular carcinomas.
Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
Oncol Rep; 2005 Jan; 13(1):95-9. PubMed ID: 15583808
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of hepatocellular carcinoma using digital subtraction imaging with the contrast agent, Levovist: comparison with helical CT, digital subtraction angiography, and US angiography.
Yamamoto K; Shiraki K; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Hashimoto A; Shimizu A; Okuda Y; Nakano T
Oncol Rep; 2002; 9(4):789-92. PubMed ID: 12066210
[TBL] [Abstract][Full Text] [Related]
5. Corona enhancement in ultrasonographical post-vascular phase images with microbubble contrast agent: a novel specific sign for hepatocellular carcinomas.
Yamamoto K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Hamataki T; Shiraki K
Oncol Rep; 2006 Apr; 15(4):785-90. PubMed ID: 16525659
[TBL] [Abstract][Full Text] [Related]
6. [Contrast-enhanced ultrasound in the diagnosis of benign and malignant hepatic tumors].
Jiang Y; Zhou Q; Zhu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):53-6. PubMed ID: 22349380
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography.
Numata K; Isozaki T; Morimoto M; Sugimori K; Kunisaki R; Morizane T; Tanaka K
World J Gastroenterol; 2006 Oct; 12(39):6290-8. PubMed ID: 17072951
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
[TBL] [Abstract][Full Text] [Related]
10. Characterization of focal hepatic tumors. Value of two-phase scanning with spiral computed tomography.
Choi BI; Han JK; Cho JM; Choi DS; Han MC; Lee HS; Kim CY
Cancer; 1995 Dec; 76(12):2434-42. PubMed ID: 8625068
[TBL] [Abstract][Full Text] [Related]
11. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
Furuse J; Nagase M; Ishii H; Yoshino M
Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
[TBL] [Abstract][Full Text] [Related]
12. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced US with Levovist for the diagnosis of hepatic hemangioma: time-related changes of enhancement appearance and the hemodynamic background.
Kobayashi S; Maruyama H; Okugawa H; Yoshizumi H; Matsutani S; Ebara M; Yokosuka O
Hepatogastroenterology; 2008; 55(85):1222-8. PubMed ID: 18795661
[TBL] [Abstract][Full Text] [Related]
15. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
16. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
[TBL] [Abstract][Full Text] [Related]
17. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US.
Isozaki T; Numata K; Kiba T; Hara K; Morimoto M; Sakaguchi T; Sekihara H; Kubota T; Shimada H; Morizane T; Tanaka K
Radiology; 2003 Dec; 229(3):798-805. PubMed ID: 14563903
[TBL] [Abstract][Full Text] [Related]
19. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
20. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US.
Kim TK; Choi BI; Han JK; Hong HS; Park SH; Moon SG
Radiology; 2000 Aug; 216(2):411-7. PubMed ID: 10924562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
